Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PPCB
PPCB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PPCB News
Propanc Signs MOU with Avance Clinical for PRP Clinical Trial
1d ago
Newsfilter
Propanc Biopharma Signs MOU with Avance Clinical for Cancer Trial
21h ago
NASDAQ.COM
Biotech Companies See Significant Stock Gains
5d ago
NASDAQ.COM
Propanc Biopharma Initiates $5M Share Repurchase Program
6d ago
seekingalpha
Propanc Biopharma Shares Surge 200% Amid Buyback Program
Jun 11 2026
stocktwits
Propanc Biopharma Authorizes $5M Share Buyback Program
Jun 11 2026
NASDAQ.COM
ShareStructure.io Launches Free Financial Education Platform
Jun 11 2026
Newsfilter
Propanc Biopharma Approves $5M Share Repurchase Program
Jun 11 2026
seekingalpha
Propanc Approves $5 Million Share Repurchase Program
Jun 11 2026
Newsfilter
Propanc Biopharma CEO Attends Keynote Address on Aging Science
Jun 02 2026
Newsfilter
Propanc Biopharma Announces 1-for-25 Reverse Stock Split
May 14 2026
Newsfilter
Propanc Biopharma Reports H1 2023 Financial Results
Feb 18 2026
seekingalpha
Propanc Publishes Key Findings on PRP's Potential Efficacy Against Pancreatic Cancer
Dec 22 2025
Globenewswire
Propanc Biopharma, Inc. Obtains Up to $100 Million in Private Placement to Enhance Digital Asset Acquisition and Speed Up R&D Initiatives
Nov 10 2025
Newsfilter
Correction: Propanc Biopharma Reveals Strategic Financing Deal Worth Up to $100 Million with Hexstone Capital
Oct 15 2025
Newsfilter
Propanc Shares Key Highlights from Fiscal Year End and Details on Therapeutic Development & $100M+ Digital Asset Treasury Plan
Oct 07 2025
Newsfilter
Show More News
